BioCorRx (BICX) Amortization of Deferred Charges (2022 - 2026)
BioCorRx (BICX) posted Amortization of Deferred Charges of $1877.0 for Q4 2025, down 94.52% sequentially from $34232.0 in Q3 2025, and down 98.15% YoY from $101725.0 in Q4 2024.
BioCorRx (BICX) Amortization of Deferred Charges (2022 - 2026) Analysis & Trends
BioCorRx has reported Amortization of Deferred Charges for 4 years, with the latest figure at $1877.0 in Q4 2025.
- Quarterly Amortization of Deferred Charges fell 98.15% year-over-year to $1877.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $4540.0 (down 99.3% YoY) and the FY2025 annual result came in at $55738.0, down 91.03% from the prior year.
- Amortization of Deferred Charges slipped to $1877.0 in Q4 2025 per BICX's latest filing, from $34232.0 in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $476539.0 in Q3 2024 and troughed at -$31569.0 in Q2 2025.
- A 4-year average of $67695.3 and a median of $30955.0 in 2023 frame the typical range for Amortization of Deferred Charges.
- The sharpest annual moves came in 2024 and 2025: Amortization of Deferred Charges jumped 1403.61% in 2024, then tumbled 289.92% in 2025.
- Over 4 years, Amortization of Deferred Charges stood at $29667.0 in 2022, then surged by 170.25% to $80176.0 in 2023, then advanced by 26.88% to $101725.0 in 2024, then slumped by 98.15% to $1877.0 in 2025.
- According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $1877.0, $34232.0, and -$31569.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn |
| 10 | BioCorRx | 1.49 Mn | 1.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,524.00 |
| Mar 31, 2026 | 10,524.00 |
| Dec 31, 2025 | 1,877.00 |
| Dec 31, 2025 | 1,877.00 |
| Sep 30, 2025 | 34,232.00 |
| Sep 30, 2025 | 34,232.00 |
| Jun 30, 2025 | -31,569.00 |
| Jun 30, 2025 | -31,569.00 |
| Mar 31, 2025 | 51,198.00 |
| Mar 31, 2025 | 51,198.00 |
| Dec 31, 2024 | 101,725.00 |
| Dec 31, 2024 | 101,725.00 |
| Sep 30, 2024 | 476,539.00 |
| Sep 30, 2024 | 476,539.00 |
| Jun 30, 2024 | 16,622.00 |
| Jun 30, 2024 | 16,622.00 |
| Mar 31, 2024 | 26,620.00 |
| Mar 31, 2024 | 26,620.00 |
| Dec 31, 2023 | 80,176.00 |
| Dec 31, 2023 | 80,176.00 |